Hand hygiene and disinfectant trial for hand-foot-mouth disease prevention in childcare centers
Part of Infections clinical trials.
This trial tests whether better hand hygiene and disinfection can reduce hand-foot-mouth disease outbreaks in childcare centers. If effective, it could help keep your child healthier and reduce missed days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your childcare center must be registered or licensed, operating for at least 2 years, and have 10 or more children enrolled.
- Your center must be located in Kota Kinabalu district.
- Your center cannot be planning to close or move during the study.
- Your center cannot be involved in another infection-prevention program at the same time.
- To participate as a staff member or parent/guardian, you must be willing and able to provide informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study simply watches children with hand, foot, and mouth disease or herpangina to learn more about these illnesses. Your child's regular care won't change, and no extra treatments are given.
This trial tests a new vaccine that protects against two common causes of hand, foot, and mouth disease, a viral illness that mostly affects young children. It may help prevent this uncomfortable and sometimes serious infection.
This study checks how long immunity lasts after receiving two doses of the EV71 vaccine. It is for children who took part in the earlier study and got either the vaccine or a placebo.
This study tests a vaccine to protect against hand, foot, and mouth disease (HFMD) caused by four common viruses. It is for healthy children aged 6 to 71 months, and aims to see if the vaccine is safe and effective.
This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.
This trial tests whether breathing in a medication called pegylated interferon helps children with mild hand, foot, and mouth disease recover faster. It is for children ages 1 to 6 who have had symptoms like fever or rash for 3 days or less.
Hear when a new Hand, Foot and Mouth Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.